FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease
Description: Lyme disease, caused by multiple species of the spirochete Borrelia burgdorferi sensu lato, is the most common tick-borne disease in the United States. Though acute illness is commonly treated by antibiotics, prolonged disease manifestations costs the U.S. health care system close to $4.8 billion a year. We are developing a pre-exposure prophylaxis to prevent LD in individuals who are at particularly high risk of infection.
Funding type: research
Funder scheme: R44
Start date: 2020-07-17
End date: 2025-04-30
Investigator: YI-PIN LIN
Institution: PLANET BIOTECHNOLOGY, INC.
Subfield: Parasitology
Field: Immunology and Microbiology
Domain: Life Sciences
Funded outputs count: 3
Funder award ID: R44AI152954
OpenAlex ID: G2201719356